Overcoming immune evasion in melanoma

K Eddy, S Chen - International journal of molecular sciences, 2020 - mdpi.com
Melanoma is the most aggressive and dangerous form of skin cancer that develops from
transformed melanocytes. It is crucial to identify melanoma at its early stages, in situ, as it is …

Melanoma: from mutations to medicine

H Tsao, L Chin, LA Garraway… - Genes & …, 2012 - genesdev.cshlp.org
Melanoma is often considered one of the most aggressive and treatment-resistant human
cancers. It is a disease that, due to the presence of melanin pigment, was accurately …

Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome

E Soura, PJ Eliades, K Shannon, AJ Stratigos… - Journal of the American …, 2016 - Elsevier
Malignant melanoma is considered the most lethal skin cancer if it is not detected and
treated during its early stages. About 10% of melanoma patients report a family history of …

[HTML][HTML] Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling

J Paluncic, Z Kovacevic, PJ Jansson… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Melanoma has markedly increased worldwide during the past several decades in the
Caucasian population and is responsible for 80% of skin cancer deaths. Considering that …

The p16INK4a/CDKN2A tumor suppressor and its relatives

M Ruas, G Peters - Biochimica et Biophysica Acta (BBA)-Reviews on …, 1998 - Elsevier
In late 1993 and early 1994, two distinct lines of research converged on a new tumor
suppressor gene located on human chromosome 9p21. The órst report was of the existence …

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents

AM Goldstein, M Chan, M Harland… - Journal of medical …, 2007 - jmg.bmj.com
Background: The major factors individually reported to be associated with an increased
frequency of CDKN2A mutations are increased number of patients with melanoma in a …

Malignant melanoma: genetics and therapeutics in the genomic era

L Chin, LA Garraway, DE Fisher - Genes & development, 2006 - genesdev.cshlp.org
Cell for cell, probably no human cancer is as aggressive as melanoma. It is among a handful
of cancers whose dimensions are reported in millimeters. Tumor thickness approaching 4 …

Decoding melanoma development and progression: identification of therapeutic vulnerabilities

K Eddy, R Shah, S Chen - Frontiers in oncology, 2021 - frontiersin.org
Melanoma, a cancer of the skin, arises from transformed melanocytes. Melanoma has the
highest mutational burden of any cancer partially attributed to UV induced DNA damage …

Geographical variation in the penetrance of CDKN2A mutations for melanoma

DT Bishop, F Demenais, AM Goldstein… - Journal of the …, 2002 - academic.oup.com
Background: Germline mutations in the CDKN2A gene, which encodes two proteins
(p16INK4A and p14ARF), are the most common cause of inherited susceptibility to …

High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL

AM Goldstein, M Chan, M Harland, EM Gillanders… - Cancer research, 2006 - AACR
GenoMEL, comprising major familial melanoma research groups from North America,
Europe, Asia, and Australia has created the largest familial melanoma sample yet available …